Loading clinical trials...
Loading clinical trials...
Prospective, Multi-Center Clinical Study of the Bard® COVERA™ Arteriovenous (AV) Stent Graft in the Treatment of Stenosis at the Graft-Vein Anastomosis of AV Graft Circuits (AVeVA)
Conditions
Interventions
Covera(TM) Vascular Covered Stent
Locations
16
United States
Arizona Kidney Disease and Hypertension Center
Phoenix, Arizona, United States
Southwest Vascular Center
Tempe, Arizona, United States
Arizona Kidney Disease and Hypertension Center Medical Research Services, LLC
Tucson, Arizona, United States
St. Joseph Hospital
Orange, California, United States
Capital Nephrology Access Center
Sacramento, California, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Start Date
July 1, 2016
Primary Completion Date
August 1, 2017
Completion Date
March 16, 2019
Last Updated
April 14, 2020
NCT04992572
NCT07477002
NCT07474935
NCT07412249
NCT07057466
NCT06886802
Lead Sponsor
C. R. Bard
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions